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Despite substantial improvements in the prevention of human immunodeficiency virus (HIV)/
Acquired Immunodeficiency Syndrome (AIDS), viral hepatitis, sexually transmitted diseases 
(STDs), and tuberculosis in the United States, some populations continue to be disproportionately 
affected by these diseases. The existence of such “health disparities” among populations 
in the United States has been discussed in the literature for several years, although there is 
not a consensus on how this term should be defined. The Department of Health and Human 
Services’ Healthy People 2010 presents a comprehensive, nationwide health promotion and 
disease prevention agenda that specifies that health disparities include “differences that occur 
by gender, race or ethnicity, education or income, disability, geographic location, or sexual 
orientation” (1). The Centers for Disease Control and Prevention (CDC) uses surveillance 
data from state and local health departments to monitor disparities and other patterns in HIV/
AIDS, viral hepatitis, STDs, and tuberculosis.  In this report, health disparities are measured by 
examining differences in HIV/AIDS, viral hepatitis, STDs, and tuberculosis surveillance data 
with respect to such sociodemographic factors as race/ethnicity, gender, and age.  In addition, 
where possible, disparities are measured by examining differences by sexual orientation and 
geographic location. 
This report includes a retrospective review of CDC surveillance data for HIV/AIDS, viral 
hepatitis, STDs, and tuberculosis over the period 2000-2004.  This time period was selected 
because at the time this report was written, 2004 was the most recent year for which surveillance 
data were available for all diseases. The inclusion of surveillance data from the same time 
period allows for comparisons between diseases. In addition to an overview of the surveillance 
data, this report includes information on some of the CDC programmatic, educational, and 
research activities that have been implemented to address health disparities related to HIV/
AIDS, viral hepatitis, STDs, and tuberculosis. An overview of CDC priorities for future action 
to address health disparities related to these diseases is also included in the report.  
Factors contributing to health disparities include poverty, unequal access to health care, and 
lower educational attainment.  Intertwined with these factors are dynamics such as racism 
and homophobia. People’s physical locations—e.g., urban vs. rural and living situation—in 
addition to social networks and social stigma, also contribute.
Burden
Blacks had the highest HIV/AIDS infection rate in 2004, with 69.3 cases per 100,000 in 
population, 8.5 times the rate for whites. Blacks accounted for 50% of all HIV/AIDS cases 
diagnosed in 2004.  In 2004, males accounted for 73% of all HIV/AIDS cases among adults 




In 2004, the overall rate of hepatitis A—1.9 cases per 100,000 in population—was the lowest 
ever recorded.  Historically, the highest rates of hepatitis A have been found among American 
Indians/Alaska Natives (AI/AN); however, these rates have dramatically decreased following 
the widespread vaccination in this group begun in 1995.  Rates of hepatitis B continue to decline 
among all racial and ethnic groups, but they remain highest among non-Hispanic blacks, with 
2.9 cases per 100,000 population.  The majority of hepatitis C cases continue to occur in adult 
age groups, with injecting drug use as the most commonly identified risk factor for infection.
Despite national progress toward syphilis elimination, syphilis remains an important problem 
in the South and in urban areas where there are large populations of men who have sex with 
other men.  Blacks have the highest rate of syphilis infections, with a rate of 9 cases per 
100,000 in population in 2004, almost three times the rate among the second highest groups, 
Hispanics and American Indian/Alaska Natives.  Blacks also had the highest gonorrhea rates, 
with 629.6 cases per 100,000 in population.  
Since 2000, there has been a 21% increase in the chlamydia rate among the 20- to 24-year-old 
group, consistently the age group with the highest rate of infection.  The 15-19 age group has 
maintained the second highest rate for this period of time, with an overall increase of 17.5%. 
Among all racial and ethnic groups, in 2004, Asians had the highest tuberculosis rate, 27.6 cases 
per 100,000 population—17 times the rate of whites. In 2004, 82% of tuberculosis cases in the 
United States occurred in racial and ethnic minorities. In addition, 54% of all cases in 2004 
occurred among foreign-born persons. Among US-born persons reported with tuberculosis in 
2004, 45% were African Americans, the highest percentage among US-born racial and ethnic 
groups.
Response
Developed through a national process, the document Healthy People 2010 identifies a set of 
10-year health objectives to be achieved during the first decade of the 21st century. It has 
two overarching goals—to increase quality and years of healthy life and to eliminate health 
disparities (1). CDC has a major leadership role in carrying out the goals set forward in Healthy 
People 2010, including the goal to eliminate racial and ethnic disparities in health.  Through 
specific objectives with measurable targets, Healthy People 2010 provides a framework by 
which programs are to achieve the Department of Health and Human Services’ vision for a 
healthier nation. A mid-year progress report provided a mid-course assessment through January 
2005. The mid-course review suggested that the nation’s health improved overall, but health 
disparities remain virtually unchanged (2).  
To help accomplish goals related to reducing health disparities, CDC has (1) launched agency-
wide and disease-specific initiatives; (2) developed culturally appropriate, community-driven 
programs; (3) collaborated with community and government partners on prevention research; 
(4) developed educational outreach activities for the community and for CDC employees; and 
(5) implemented programs to increase diversity in the public health workforce.
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CDC has developed several strategic planning documents addressing the task of reducing health 
disparities. For example, in January 2001, CDC released a 5-year HIV Prevention Strategic 
Plan, with an overarching goal of significantly reducing the number of new HIV infections. 
The plan was later updated in 2007.  However, disparities continue to persist in HIV/AIDS 
among racial and ethnic minority populations, especially among African Americans. To 
further reduce the incidence of HIV, in 2003, CDC launched Advancing HIV Prevention: New 
Strategies for a Changing Epidemic.  In 2007, CDC launched A National Heightened Response 
to the HIV/AIDS Crisis Among African Americans.  The National Plan to Eliminate Syphilis 
was launched in 1999, resulting in substantial reductions in cases among African-American 
women. A revised plan was launched in 2006. A project to vaccinate AI/AN children routinely 
against hepatitis A and the “Stop TB in the African-American Community” initiative have also 
shown progress.
CDC provides leadership, capacity-building assistance, and funding for programs at the state, 
local, and community levels for the prevention and control of HIV/AIDS, viral hepatitis, 
STDs, and tuberculosis. The funding supports staffing, program infrastructure, program 
implementation, and evaluation of interventions. Many program activities target groups 
disproportionately affected by these diseases.  Among these programs providing interventions 
and services to many racial and ethnic minorities are the Replicating Effective Programs (REP) 
project for HIV prevention; the Infertility Prevention project, which focuses on chlamydia and 
gonorrhea; and the US-Mexico Binational Referral and Case Management project, targeting 
tuberculosis patients who migrate across the US-Mexico border.
CDC’s research agenda includes studies to monitor patterns of disease in different populations 
as well as to further understand and address health disparities through intervention research. 
The results of these studies will be used to develop and evaluate programs to address health 
disparities in HIV infection, viral hepatitis, STDs, and tuberculosis.
Education and outreach are other tools for helping eliminate health disparities. Educational 
and training efforts are directed toward those who can aid in this effort, including legislators, 
health professionals, community leaders, academicians, journalists, and representatives from 
the faith, business, and entertainment communities. 
Finally, in order to address the healthcare needs of this nation’s diverse population in an 
effective and culturally sensitive manner, CDC has implemented training programs and related 
activities to help ensure that the public health workforce is also diverse.  The training programs 
focus primarily on increasing the interest, representation, and competence of racial and ethnic 
minority students, researchers, and health professionals in public health.
In addition to CDC’s existing efforts to address health disparities in the incidence of HIV/
AIDS, viral hepatitis, STDs, and tuberculosis, the following are priorities for future action: 
1) enhancing and improving partnerships; 2) increasing screening and testing for diseases in 
populations with known health disparities; 3) adopting an integrated service model to improve 
health care delivery; 4) improving monitoring through the enhancement of current data 




No single public health program can eliminate racial and ethnic, socioeconomic, and gender 
inequities or homophobia. However, CDC will continue to work with community partners, 
healthcare providers, legislators, and other stakeholders to identify collaborative activities that 
may influence some of the social determinants that contribute to health disparities in HIV/





Despite substantial improvements in the prevention of HIV/AIDS, viral hepatitis, sexually 
transmitted diseases (STDs), and tuberculosis in the United States, some populations continue to 
be disproportionately affected by these diseases. For example, blacks and Hispanics accounted 
for nearly 67% of the estimated cases of HIV/AIDS diagnosed in 2004. In 2004, rates of 
hepatitis B were higher among blacks than for whites, Asians/Pacific Islanders, American 
Indians/Alaska Natives, and Hispanics. Blacks and American Indians/Alaska Natives had 
higher rates of gonorrhea in 2004 than whites, Asians/Pacific Islanders, and Hispanics. While 
overall tuberculosis rates continued to decline in 2004, 82% of all reported tuberculosis cases 
occurred in racial and ethnic minorities. As the nation’s population becomes more diverse 
demographically, efforts to improve health will require a closer examination of differences in 
risk factors for disease, as well as in differences in access to and use of health care services. 
CDC, which has been a leader in addressing disparities in disease, receives many requests for 
public health information about different population subgroups. 
Developed through a national process, Healthy People 2010 identifies a set of 10-year health 
objectives to achieve during the first decade of the 21st century. It has two overarching goals—
to increase quality and years of healthy life and to eliminate health disparities (1). CDC has a 
major leadership role in carrying out the goals set forward in Healthy People 2010, including 
the goal to eliminate racial and ethnic disparities in health.  Through specific objectives with 
measurable targets, it provides a framework for programs to achieve the Department of Health 
and Human Services’ vision for a healthier nation. A mid-year progress report provided a mid-
course assessment through January 2005. The mid-course review suggested that the nation’s 
health improved overall, but health disparities remain virtually unchanged (2).  
CDC uses surveillance data from state and local health departments to monitor disparities 
and other patterns in HIV/AIDS, viral hepatitis, STDs, and tuberculosis.  In this report, health 
disparities are measured by examining differences in HIV/AIDS, viral hepatitis, STDs, and 
tuberculosis surveillance data with respect to such sociodemographic factors as race/ethnicity, 
gender, and age.  In addition, where possible, disparities are measured by examining differences 
by sexual orientation and geographic location. 
This report includes a retrospective review of CDC surveillance data for HIV/AIDS, viral 
hepatitis, STDs, and tuberculosis between 2000-2004.  This time period was selected because 
at the time this report was written, 2004 was the most recent year for which surveillance 
data were available for all diseases. The inclusion of surveillance data from the same time 
period allows for comparisons between diseases. In addition to an overview of the surveillance 
data, this report includes information on some of the CDC programmatic, educational, and 
research activities that have been implemented to address health disparities related to HIV/
AIDS, viral hepatitis, STDs, and tuberculosis. An overview of CDC priorities for future action 
to address health disparities related to these diseases is also included in the report. This is the 
first analysis of health disparities across all of the diseases included in the National Center 
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for HIV/AIDS, Viral Hepatitis, Sexually Transmitted Diseases, and Tuberculosis Prevention 
(NCHHSTP).  Future reports will include updated surveillance data, additional data analyses 
among demographic variables to further describe health disparities, as well as a description of 
additional efforts CDC is undertaking to address health disparities related to HIV/AIDS, viral 




How Are Health Disparities Defined?
The term health disparity is used almost exclusively in the United States. Health inequality and 
health inequity are more commonly used outside this country. There is little consensus about 
how these terms should be defined (3-19). The Department of Health and Human Services’ 
Healthy People 2010, which presents a comprehensive, nationwide health promotion and 
disease prevention agenda, specifies that the term health disparities designates “differences 
that occur by gender, race or ethnicity, education or income, disability, geographic location, or 
sexual orientation (1).”  According to some definitions, health disparities are differences in the 
incidence, prevalence, mortality, and burden of diseases and other adverse health conditions that 
exist among specific population groups in the United States (15). Another definition describes 
a health disparity in a population as “. . . a significant disparity in the overall rate of disease 
incidence, prevalence, morbidity, or survival rates in the population as compared to the health 
status of the general population.” (16). Other definitions of health disparities examine the role 
of social status and control over one’s life as important influences on health disparities (19). 
Some definitions of health disparities suggest that the health differences between individuals 
or social groups are in some way unfair and avoidable (3-4).
What Factors Contribute to Health Disparities?
Many factors contribute to disparities in the distribution of disease.  They include poverty, 
unequal access to health care, and lower educational attainment (20-25). Racism is intertwined 
with these factors (20, 21, 24, 25). For example, racial and ethnic discrimination in employment 
may restrict access to higher paying jobs, making it difficult to pay for health care. In 2004, 24.7% 
of blacks and 21.9% of Hispanics lived in poverty; these are the highest percentages across all 
racial and ethnic groups (26). The percentage of uninsured Hispanics (32.7%) was higher than 
the percentages of blacks (19.7%), Asians (16.8%), and whites (14.9%) (26). Among foreign-
born persons, 44.1% of those who were not citizens lacked insurance coverage compared with 
17.2 % of naturalized citizens. The percentage of persons without health insurance was also 
high among persons with household incomes less than $25,000 (24.3%) and between $25,000 
and $49,999 (20.0%), compared to higher income groups.
Persons from racial and ethnic minority populations may have poor access to health and medical 
services and inconsistent relationships with health care providers because of the lack of doctors 
in many minority communities (27). A 1997 study of physician practice found that wealthier 
areas had 33 to 50 times more physicians than poorer areas (28). In addition, discrimination 
in education that affects literacy skills can mean that messages regarding risk and prevention 
are inaccessible (29). Between October 2002 and October 2003, Hispanic students were more 
likely to drop out of high school than white students, Asian students, and black students; 
students living in low-income families were approximately five times more likely than their 
peers in high-income families to be drop-outs (30). Language barriers also contribute to health 
disparities.  In 2000, of 47 million people in the United States (18% of the total population 
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aged 5 and over) who reported they spoke a language other than English at home, 45% reported 
they spoke English less than “very well” (31). 
The physical locations (e.g., prisons) and social networks within which people interact can 
promote or encourage risky health behaviors (32) and may account for some health disparities. 
Following changes in U.S. drug policy in the 1980s, the number of individuals in prisons 
increased dramatically. It has been reported that, while the number of white prisoners incarcerated 
for drug offenses rose by a factor of seven between 1983 and 1998, Hispanic drug-related 
incarcerations increased 18-fold, and African-American drug incarcerations increased more 
than 26-fold (33). Compared with the general population, persons incarcerated in correctional 
systems have a disproportionately greater burden of infectious diseases, including HIV, viral 
hepatitis, STDs, and tuberculosis infections (34). In general, studies suggest that while sex 
and drug use decrease overall among incarcerated persons, sex and drug use behaviors are 
conducted in a riskier manner inside prison than outside (35, 36). Although it is difficult to 
assess whether African Americans and whites have different risks of transmitting sexually 
transmitted diseases (STDs) while in prison, some studies indicate that there are few differences 
in their risk behaviors during incarceration (35, 37). This suggests that any association between 
incarceration and black-white disparities in STDs relating to prison as a risk environment 
results from the greater likelihood that African Americans will be exposed to this environment 
(38). Rates of STDs and tuberculosis are also higher among persons within the correctional 
system (39-41).
The social networks, especially sexual networks, of individuals influence their risks of acquiring 
and transmitting infectious diseases. The term sexual network refers to a set of people who are 
linked directly or indirectly through sexual contact (42, 43). Recent studies suggest that there 
are differences between blacks and whites in the type and number of partners they include 
in their sexual networks (44-46). These differences have been influenced by some of the 
same factors that contribute to health disparities (e.g., residential segregation by race, high 
incarceration rates among African-American males, and poverty).  In one analysis, the data 
indicated that STDs remain high within the black population because they are more likely than 
other racial and ethnic groups to choose other African Americans as partners, and this group 
bears a disproportionate burden of STDs (47). Other potential factors with direct relevance to 
sexual networks and the transmission of STDs include targeted marketing of legal and illegal 
psychoactive substances, inadequate health care from healthcare facilities and from specific 
providers, factors that alter the ratio of women to men, and forces that discourage long-term 
stable relationships (48).
Social stigma also contributes to health disparities (24). Like racial and ethnic minorities, sexual 
minorities, including lesbian, gay, bisexual, and transgender individuals, also experience a wide 
range of health disparities (49-52). A growing number of studies have examined disparities 
among sexual minorities, documenting significant differences in rates of disease, mental 
health, and risk behaviors that can lead to poor health. Negative societal attitudes towards 
homosexuality by some may contribute to social stigma experienced by sexual minorities that 
contribute to health disparities. Although homophobia cuts across racial lines, many racial and 
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ethnic minority men who have sex with men (MSM) remain secretive about their sexuality 
because of a historical lack of acceptance by leaders and religious institutions within their 
communities.  Keeping secrets, including concealing one’s own sexual orientation, can have 
a negative effect on the individual’s health (53-58). For example, research with MSM living 
with HIV has shown that hiding sexual orientation is associated with more rapid progression 
of HIV-related illness (53-58).  In addition, some men also have sex with women but do not 
disclose their sexual relationships with men. It is difficult to assess the extent to which lack of 
disclosure contributes to rates of STDs in women, especially women from racial and ethnic 
minority populations.  In one review of the literature on bisexual black men, HIV risk, and 
heterosexual transmission, the authors found that black MSM were more likely than MSM 
of other races and ethnicities to be bisexually active (59). Their data also revealed that black 
MSM who did not disclose their homosexual or bisexual activities to their partners engaged in 
fewer sexual risks than black MSM who are open about their sexuality (59).  They concluded, 
however, that the high prevalence of HIV infection in the African-American community and 
the greater likelihood of bisexuality among black men place heterosexual African-American 
women at risk for HIV infection (59). 
How Are Health Disparities Measured?
There is little consensus about how to measure health disparities (12, 60-69). Several issues are 
important in choosing health disparity measures. For example, should one measure disparities 
between or within different populations? Comparing health outcomes in one population with 
outcomes in another may mask differences that exist within each group. Another issue in 
choosing disparity measures is the selection of the comparison group. Should the rate of a 
disease in a group that is disproportionately affected be compared with the rate in the general 
population, the majority population, or the population with the lowest rate of the disease? The 
results one would get may differ according to which groups are compared. Some measures 
of health disparities that have been used include measures of “total disparity” (68), measures 
of “disproportionality” (69), and measures of “social-group disparity” (12). Measuring total 
disparity in health involves evaluating the distribution of health among all individuals in 
a population, without regard to their social group membership (61). One limitation of this 
measure is that it does not distinguish differences between social groups (e.g., racial, ethnic). 
Describing health disparity in terms of disproportionality—i.e., a “disproportionate share” or 
an “unequal burden”—implies that it is unfair that some groups experience more ill health than 
others (61).  
Social group disparity, which is the basis for one of the overarching goals in Healthy People 
2010, measures differences between individuals from social groups (1). HHS uses a “progress 
quotient” to monitor progress toward Healthy People 2010 targets.  The quotient measures the 
percentage of targeted change that was achieved. To compare the remaining progress needed 
among population subgroups, an absolute measure of the difference remaining between the 
target and the most recent data value is used. One of the challenges in using social group 
disparity as a measure of health is choosing social groups that are comparable for the purpose 
of measuring disparities over time. 
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What Data Do CDC Use to Monitor Health Disparities in HIV/AIDS,
Viral Hepatitis, STDs, and Tuberculosis?
Surveillance data are used by the CDC to monitor disparities and other patterns in HIV/AIDS, 
viral hepatitis, STDs, and tuberculosis. CDC funds and assists state and local health departments, 
which collect the data and report it to CDC. The ultimate surveillance goals for these diseases 
are nationwide systems that combine information on existing cases, new infections, and 
behaviors and characteristics of people at risk, so that CDC can monitor national disease trends 
and direct prevention funding to where it is needed most. In 2004, AIDS data were collected 
by all 50 states, the District of Columbia, U.S. dependencies and possessions, and independent 
nations. HIV infection data were reported by 35 areas (33 states, Guam, and the Virgin Islands) 
with confidential name-based reporting since at least 2000. In 2004, all 50 states collected data 
about acute hepatitis A, acute hepatitis B, and acute hepatitis C. In 2004, reports of tuberculosis 
cases were submitted to CDC by 60 reporting areas (50 states, the District of Columbia, New 
York City, Puerto Rico, and seven jurisdictions in the Pacific and Caribbean). In the same 
year, cases of nationally notifiable sexually transmitted diseases were reported by 50 states, 
the District of Columbia, selected cities, U.S. dependencies and possessions, and independent 
nations in free association with the United States. Although there are differences in the data 
collection and reporting systems for these diseases, core surveillance data are similar. For 
example, data on age, race and ethnicity, and sex are collected for all the systems. HIV/AIDS 
and viral hepatitis surveillance data, however, also include risk behavior and exposure data 
(e.g., intravenous drug use). Tuberculosis and HIV/AIDS data include nativity and country 
of origin. STD surveillance includes data from persons entering correctional facilities, and 





The Burden of Disease
Surveillance data on specific racial or ethnic groups, geographic regions, genders, or age groups 
can help identify health disparities among those groups or regions. In the following section of 
this report, surveillance data submitted to CDC are used to describe the overall burden of HIV/
AIDS, viral hepatitis, STDs, and tuberculosis in the United States during the period 2000-2004 
and how this burden is greater among certain population groups than in others.
HIV/AIDS
HIV is the pathogen responsible for AIDS.  HIV attacks the immune system and undermines its 
function, allowing opportunistic infections and malignancies to occur.   HIV infection is spread 
by sexual intercourse, intravenous drug use, perinatal transmission, transfusion of blood and 
blood products, organ transplantation, and occupational exposure to HIV-contaminated blood 
or body fluids.  
This report includes estimated numbers of cases of HIV/AIDS from surveillance data from 
the 35 areas (33 states, Guam, and the US Virgin Islands) with integrated HIV and AIDS 
surveillance since at least 2000.  Surveillance data on HIV infections provides a clearer picture 
of the epidemic and of the need for prevention and care services than does the picture provided 
by AIDS data by itself.  However, the number of new HIV diagnoses does not necessarily 
reflect trends in HIV incidence, because some newly diagnosed persons were infected recently, 
while others were infected some time in the past.  The numbers presented for HIV/AIDS are 
combined rates, and they include newly diagnosed HIV infection cases and newly diagnosed 
AIDS cases.  The overall rate of HIV/AIDS in 2004 was 18.8 cases per 100,000 population, 




Blacks had the highest HIV/AIDS infection rate in 2004, with 69.3 cases per 100,000 
population—8.5 times the rate for whites—and blacks accounted for 50% of all HIV/AIDS 
cases diagnosed in 2004.  Hispanics had the second highest rate, with 26.6 cases per 100,000 
population, followed by Indians, whites, and Asians with 10.2, 8.2, and 6.5, respectively.  A 
decrease in rates was observed in blacks and Hispanics of 19.3% and 24.6%, respectively, 
between 2001 and 2004.  In this same period, rates among whites, Indians, and Asians increased 
3.5%, 12.3%, and 16.5%, respectively (Figure 1).
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The Northeast region had the highest rates of HIV/AIDS infection in 2004, with 30.1 cases 
per 100,000 population, followed by the South with 23.5 cases per 100,000 population, the 
West with 11.3 cases per 100,000 population, and the Midwest with approximately 8 cases per 
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In 2004, males accounted for 73% of all HIV/AIDS cases among adults and adolescents.  Also 
in 2004, the HIV/AIDS rate for males was 27.8 cases per 100,000 population, 2.75 times 
greater than the rate for females for that year (10.1 cases per 100,000 population) [Figure 3].
BACK TO TABLE
OF CONTENTS
The largest number of HIV/AIDS cases occurred among persons age 35-39 years, and these 
cases accounted for 17% of all HIV/AIDS cases diagnosed in 2004.  In 2004, the group with 
the highest HIV/AIDS rates consisted of those 35-39 years of age, with 45.9 cases per 100,000 
population; however, the rates for this group have consistently decreased since 2001, with a 
total decline of 19.4%.  Since 2001, all groups had a decline in their rates except for the age 
group 20-24 years; that group had an increase of 3.4% (Figure 4).
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MSM experience the greatest burden of HIV/AIDS among adult males. From 2001 through 
2004, the estimated number of HIV/AIDS cases increased among men who have sex with men 
(MSM).  In contrast the estimated number of HIV/AIDS cases decreased among drug injection 
users (IDU), MSM who were also IDU, and heterosexuals.  MSM (65%) and males exposed 
through heterosexual contact (16%) accounted for approximately 80% of all HIV/AIDS cases 
diagnosed in 2004 (Figure 5). 
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For females, the most common transmission mode for HIV/AIDS is heterosexual contact.  In 
2004, heterosexual contact accounted for approximately 78% of all the cases diagnosed that 
year.  Injection drug use accounted for 20% of HIV/AIDS cases.
AIDS
AIDS has metamorphosed from an epidemic in the 1980s to a pandemic in the 1990s and 
2000s.  The estimated rate of newly diagnosed persons with AIDS in the United States for 2004 
was 13.5 cases per 100,000 population; this rate decreased 2.5% from the rate in 2001—13.9 
cases per 100,000 population. 
From 2000 through 2004, the estimated number of AIDS cases increased among all racial 
and ethnic groups.  Blacks had the highest rate of AIDS in 2004, with 54.5 cases per 100,000 
population, approximately 9 times the rate of whites, who had 5.8 cases per 100,000 population. 
Hispanics were the racial/ethnic group with the second highest rate, 17.3 cases per 100,000 
population, followed by AI/AN, whites, and Asians, with 7.7, 5.8, and 3.6 per 100,000 
population, respectively.  Hispanics were the only group that experienced a decline (6.2%) 
in AIDS rates between 2000 and 2004.  AIDS rates for blacks remained stable, and rates for 
whites, AI/AN, and Asians increased 4.7%, 9.2%, and 16%, respectively (Figure 6).   
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Historically, the Northeast region has had the highest rate for AIDS. Although in 2004 the 
region experienced a decline, it was still the region with the highest rate for 2004, (18.8 
cases per 100,000 population).  It was closely followed by the South (17.9 cases per 100,000 
population).  The West and Midwest had approximately half the rates of the Northeast and 
South, with 9.2 and 6.5 cases per 100,000 population, respectively.  Both the South and the 
Midwest had increases (10.3% and 7.8%, respectively) since 2001; and the Northeast and the 
West experienced declines (9.6% and 5.7%, respectively).
 
From 2000 through 2004, the estimated number of AIDS cases increased 10% among females 
and 7% among males.  Males accounted for 73% of all AIDS cases diagnosed in 2004.  In 
2004, AIDS rates were 20.1 cases per 100,000 population for males and 7.2 cases per 100,000 
population for females.  The rate for males was 2.8 times that of females.
From 2000 through 2004, the estimated number of AIDS cases decreased 61% among children 
less than 13 years of age.  The greatest number of cases occurred among persons aged 40-44 
years, accounting for 21% of all AIDS cases diagnosed in 2004.
In 2004, the group with the highest AIDS rate was persons aged 35–39 years (35.6 cases per 
100,000 population) [Figure 7]. 
Among men, MSM (58%) and persons exposed through heterosexual contact (16%) accounted 
for approximately 75% of AIDS cases in 2004.  MSM cases of AIDS increased by 10% from 
2001 to 2004.  Intravenous drug users accounted for 18% of all AIDS cases in 2004, but this 
group showed a decline of 11% since 2001.  For females, 7,489 AIDS cases were due to 
heterosexual contact, approximately 70% of all cases in 2004.  There has been an increase 
(11%) in the number of AIDS cases by this transmission category since 2001.  Transmission 
through injection drug use showed a slight decrease for females, from 3,393 cases to 3,184 




Hepatitis A is a liver disease caused by the hepatitis A virus (HAV). Hepatitis A can affect 
anyone. In the United States, hepatitis A can occur in situations ranging from isolated cases of 
disease to widespread epidemics.  Hepatitis B is a serious disease caused by a virus that attacks 
the liver. The virus, which is called hepatitis B virus (HBV), can cause lifelong infection, 
cirrhosis (scarring) of the liver, liver cancer, liver failure, and death.  Hepatitis C is a liver 
disease caused by the hepatitis C virus (HCV), which is found in the blood of persons who 
have the disease. HCV is spread by contact with the blood of an infected person.
From 2000-2004, rates for hepatitis A, hepatitis B, and hepatitis C have declined.  For hepatitis 
C, a 73% decline was observed from 2000 to 2004. During this time period, a 60% and a 28% 
decline were observed for hepatitis A and hepatitis B, respectively (Figure 8).
Hepatitis A
Hepatitis A has historically been one of the most frequent notifiable diseases in the United 
States.  However, with the 1995 introduction of vaccines to prevent hepatitis A virus infection, 
there has been a substantial reduction in disease incidence.  In 2004, the overall rate of hepatitis 
A, 1.9 cases per 100,000 population, was the lowest ever recorded.  With the introduction of 
vaccines, the epidemiologic profile of this disease has experienced changes in the past years, 
with an increase in the proportion of cases occurring among adults, particularly those in high-
risk populations, such as international travelers and MSM.  Rates of hepatitis A have been 
historically higher among males. During the late 1990s through 2001, the difference in the 
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gender-specific rates increased in such a way that rates in males were approximately double 
the rates of females.  However, since 2001, rates have declined more in males, and in 2004, 
hepatitis A rates were 2.1 cases per 100,000 population for males and 1.8 cases per 100,000 
population for females.
Historically, hepatitis A rates have differed by race, with the highest rate among AI/AN and the 
lowest rate among Asians.  However, rates among AI/AN, which were greater than 60/100,000 
prior to 1995, have decreased dramatically following widespread vaccination in this group, 
and since 2001, the rates have been approximately the same or lower than those of other 
races. By ethnicity, rates are higher among Hispanics than among non-Hispanics. Rates among 
Hispanics have also decreased since 1997, but they remain higher than those for non-Hispanics 
(Figure 9).
Hepatitis A rates have consistently been higher in the West than elsewhere in the country. 
However, in 2004, the Northeast had the highest hepatitis A rate, with 3.4 cases per 100,000 
population, followed by the West, Southeast, and Midwest, with rates of 2.2, 1.8, and 1.1 cases 
per 100,000, respectively. 
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The incidence of hepatitis A varies by age group.  Rates have declined among all groups, but 
the greatest decreases have been among children. In 2004, rates were similar across all age 
groups, ranging from a low of 1.5 per 100,000 among children <5 years of age to 2.2 per 
100,000 among persons 5-14 years old.  The low and relatively stable rates among persons 
40+ years of age in large part reflect the higher proportion of persons in this age group with 
immunity due to previous infection (Figure 10).
Hepatitis B
In 2004 the number of reported cases of hepatitis B was 6,212. The overall incidence rate 
of hepatitis B was 2.1 cases per 100,000 population.  This rate is the lowest recorded, and it 
represents a decline of 27.6% since 2000.
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Rates of hepatitis B are not only low, but also continue to decline among all racial and ethnic 
groups.  Rates of hepatitis B remain highest among non-Hispanic blacks, with 2.9 cases 
per 100,000 population, and they are the lowest among Hispanics, with 1 case per 100,000 
population, a rate lower than that of non-Hispanic whites, 1.3 cases per 100,000 population 
(Figure 11).  
In 2004, hepatitis B rates were similar in the West, Midwest, and Northeast, with 1.8, 1.4, and 
2.1 cases per 100,000 population, respectively, but the rate remained higher in the Southeast 
(3.2 cases per 100,000 population).
The rate of hepatitis B in males in 2004 was 2.7 per 100,000 population; for females, the rate 
was 1.6 cases per 100,000 population.  The ratio of cases among males to cases among women 




Rates have declined in all age groups.  Hepatitis B rates vary by age, with the highest rates 
among persons 25-39 years of age (4.5 cases per 100,000 population) and the lowest among 
persons less than 15 years of age (.08 cases per 100,000 population) [Figure 12].  The greatest 
percentage decline occurred among children <15 years of age–a 95% decrease in rate–and 
among young adults aged 15-24, with an 87% decline. Although less dramatic than the declines 
in the younger age groups, substantial decreases in hepatitis B rates have occurred among  25- 
to 44-year-olds (71%) and among those older than 45 (51%).
Hepatitis C
Hepatitis C virus is the most common bloodborne infection in the United States, with an 
estimated 3.2 million chronically infected persons nationwide.  The incidence of hepatitis C 
has declined since the late 1980s. The majority of hepatitis C cases continue to occur among 
adults, with injecting drug use as the most commonly identified risk factor for infection.  In 
2004, there were 758 cases of confirmed acute hepatitis C (0.3 cases per 100,000 population).
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The incidence of hepatitis C has declined in all racial groups since 1995. In 2004, rates were 
similar across racial and ethnic groups, ranging from 0.06/100,000 among Asian/Pacific 
Islanders to 0.57/100,000 among American Indian/Alaska Natives (Figure 13).  
  
As in previous years, the rate of hepatitis C in 2004 is higher among males, with a rate of 0.3 
per 100,000 population, than in females, with a rate of 0.2 per 100,000 population.  However, 
this difference has diminished over the decade, and in 2004 the ratio of male to female rates 
was the smallest observed since reporting began.
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Hepatitis C rates vary by age, with the highest rates in 2004 among persons 25-39 years of 
age (.04 cases per 100,000 population) and the lowest among persons less than 15 years of age 
(Figure 14).  Hepatitis C rates have been declining in all age groups since the mid-1990s.  The 
greatest decline in incidence has been among 25- to 39-year-olds, which has historically been 
the age group with the highest rates of disease.  In this group, incidence has declined by 62% 
since 2000, to 0.4 cases per 100,000 population.  
Sexually Transmitted Diseases
Primary and Secondary Syphilis
Syphilis is a genital ulcerative disease caused by the bacterium Treponema pallidum that 
facilitates the transmission of HIV and may be important in contributing to HIV transmission 
in those parts of the country where rates of both infections are high.  Despite national progress 
towards syphilis elimination, syphilis remains an important problem in the South and in urban 
areas with large populations of MSM.   In 2000, the rate of primary and secondary syphilis 
was the lowest reported since 1941. Syphilis rates declined by 89.2% from 1990 through 2000. 
However, these rates increased from 2000 to 2004, primarily because of increases in syphilis 
among men.  In 2004, primary and secondary syphilis cases reported to the CDC increased to 
7,980 from 7,177 in 2003, an increase of 11.2%.
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In 2004, blacks had the highest rate of syphilis infections (9 cases per 100,000 population), 
almost three times the rate of Hispanics and AI/AN, both the latter groups with a rate of 3.2 
cases per 100,000 population.  Rates in Hispanics have doubled between 2000 and 2004, rates 
among whites have tripled, and rates for Asians/Pacific Islanders have quadrupled.  In 2004, 
the African-American rate was 5.6 times the rate among whites, reflecting a substantial decline 
from 2000, when the rate among African Americans was 24 times greater.  This decline in the 
ratio is partially a reflection of actual decreases among African Americans, but it is also partly 
attributable to increases among whites (Figure 15).
In 2004, the South had the highest rates of syphilis infection (3.6 cases per 100,000 population); 
in fact, the South accounted for 48% of syphilis cases (16,302 cases) reported that year.  During 
2003–2004, rates increased in all US regions except the Midwest; the Northeast region rate 
increased 4.8%, the West 7.4%, and the South 16.1%.  All these rates were greater than the 
Healthy People 2010 target of 0.2 cases per 100,000 population.
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Overall increases in rates of syphilis during the period 2000–2004 were observed only among 
men.  In the last 5 years, male rates of syphilis have increased from 2.5 to 4.7 cases per 100,000 
population, representing an 11.9% increase. In 2004, male rates were 5.2 times female rates 
(Figure 16).  The male-to-female rate ratio for primary and secondary syphilis has been on the 
rise since 1996. The increase is primarily attributable to increases in syphilis among MSM.
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In 2004, the age group with the highest syphilis rate consisted of individuals between 35 and 
39 years, and, from 2001 to 2004, this group has had the highest syphilis rate.  This group 
experienced an increase of 26%.  Individuals between the ages of 30 and 34 have had the 
second highest syphilis rate, with an overall increase of 24% since 2001 (Figure 17).
Gonorrhea
Gonorrhea is the second-most commonly reported notifiable disease in the United States. 
Infections due to Neisseria gonorrhoeae are a major cause of pelvic inflammatory disease (PID). 
PID can lead to serious outcomes, such as tubal infertility, ectopic pregnancies, and chronic 
pelvic pain.  There is strong epidemiologic evidence that gonococcal infections facilitate the 
transmission of HIV infection.
 
The number of gonorrhea cases reported in the United States in 2004 was 330,132 (113.5 cases 
per 100,000 population).  Although this is the lowest gonorrhea rate the United States has ever 
reported, it still considerably exceeds the Healthy People 2010 target of 19 cases per 100,000 
population.  Gonorrhea rates decreased 11.8% between 2000 and 2004, but true changes in 
rates may be masked by changes in screening practices, use of diagnostic tests with different 
sensitivities, and changes in reporting practices.  
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In 2004, blacks had the highest gonorrhea rates (629.6 cases per 100,000 population).  Although 
rates among blacks decreased annually since 2000, the rate is nevertheless approximately 6 
times that of AI/AN, more than 18 times that of whites, and almost 30 times the rate of Asians/
Pacific Islanders (Figure 18).
In 2004, the South was the geographic region with the highest gonorrhea rate (143.5 cases per 
100,000 population), but that rate still represents a decline of 22% from a rate of 184 cases per 
100,000 in 2000.  This rate is closely followed by the Midwest, with a rate of 134.3 cases per 
100,000 population.  In contrast, the gonorrhea rate in the West increased by 27.3%, from 57.2 
cases per 100,000 population in 2000 to 72.8 in 2004.  Rates in the Northeast, 80.6 in 2004, 
and the Midwest, 134.3 in 2004, have shown minimal changes since 2000.  
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Prior to 1996, rates of gonorrhea among men were higher than rates among women.  However, 
since 2001, gonorrhea rates among women have increased, and, in 2004, they were slightly 
higher than in men.  In 2004, the gonorrhea rate among women was 116.5; it was 110.0 cases 
per 100,000 population among men (Figure 19).
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In 2004, the age group with the highest gonorrhea rate consisted of individuals between 20 
and 24 years, with a rate of 497.8 per 100,000 population.  Since 2000, there has been a 15.4% 
decrease in the rate of gonorrhea among 15- to 19-year-olds and a 15.2% decrease among 20- 
to 24-year-olds, greater than in any other age group.  Decreases over this period of time were 
greater among males than females (Figure 20).
Chlamydia
Chlamydia trachomatis infection is the most commonly reported sexually transmitted disease 
(STDs) in the United States, and increases in infection have been reported over the past 10 
years.  In men, the most common syndrome is chlamydial urethritis, typically presented as 
mucoid discharge associated with dysuria and urethral itching.  In women, cervical infection 
is the most commonly reported syndrome, but the infection is usually asymptomatic.  If left 
untreated, approximately 30% of women with chlamydial infection develop pelvic inflammatory 
disease (PID).  PID is associated with high rates of subsequent infertility, ectopic pregnancy, 
and chronic pelvic pain.  In homosexual men who have had unprotected receptive anal sex, the 
most commonly reported syndrome is chlamydial proctitis.  As with other inflammatory STDs, 
chlamydia infection can facilitate the transmission of HIV infection.  In addition, infected 
pregnant women can pass the infection to their infants during delivery, potentially resulting in 
neonatal ophthalmia and pneumonia.
The increase in reported infections reflects expansion of chlamydia screening activities, use 
of increasingly sensitive diagnostic tests, increased emphasis on case reporting from providers 
and laboratories, and improvements in the information systems for reporting.
BACK TO TABLE
OF CONTENTS0
In 2004, blacks had the highest chlamydia rates (1,209.4 cases per 100,000 population), 
approximately two times the rate for AI/AN (705.8 cases per 100,000 population) and 8.4 
times that of whites (143.6 cases per 100,000 population). Chlamydia rates have increased 
annually for all racial/ethnic groups, except for Asians/Pacific Islanders (Figure 21).
The Midwest region reported the highest chlamydia rates in 2004 (340.1 cases per 100,000 
population), closely followed by the South and the West with rates of 331.4 and 323.1 cases per 




Chlamydia rates for males in 2004 were 147.5 cases per 100,000 population; for females, this 
number was more than three times the male rate, 486.2 cases per 100,000 population (Figure 
22), likely reflecting a greater number of women screened for this infection. The lower rates 
among men suggest that many of the sex partners of women with chlamydia are not diagnosed 
or reported.  
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In 2004, chlamydia rates were highest among 20- to 24-year-olds (Figure 23).  Since 2000, 
there has been a 21% increase in the chlamydia rate among this group.  Chlamydia rates are 
second highest among 15- to 19-year-olds, and during the period 2000-2004, rates for this 
group increased 17.5%.
Tuberculosis
Tuberculosis (TB) is a complex communicable disease and a major cause of disability and 
death in most of the world, especially in developing countries.  Tuberculosis generally affects 
the lungs and respiratory tract, but it can strike nearly any organ system in the body.  It is caused 
by Mycobacterium tuberculosis and less commonly by the related bacteria M. africanum and 
M. bovis, collectively referred to as tubercle bacilli.  In the 1980s and 1990s, reductions in 
tuberculosis prevention and control programs coincided with the rise of the HIV epidemic, and 
tuberculosis rebounded.  In 1999, the World Health Organization ranked tuberculosis among 
the most serious health threats in the world.
Tuberculosis rates have declined since 1993.  In 2004, a total of 14,517 tuberculosis cases were 
reported to CDC from the 50 states and the District of Columbia, representing a 2.3% decrease 
from 2003 and 11% from 2000.  Tuberculosis case rates have decreased annually from 5.8 




All racial and ethnic minority groups have rates of active tuberculosis at least five times higher 
than the rate for the white population. In 2004, Asians had the highest tuberculosis case rate, 
27.6 cases per 100,000 population, 17 times the rate of whites (Figure 24).  In 2003, the category 
Asian/Pacific Islander was split into the categories Asian and Native Hawaiian/Other Pacific 
Islander; results for these categories were first reported for 2003.   In 2004, 82% of tuberculosis 
cases in the United States occurred in racial and ethnic minorities: 29% in Hispanics, 28% in 
blacks or African Americans, 23% in Asians, and 1% among AI/AN and Native Hawaiians/
Other Pacific Islanders.  Among US-born persons reported with tuberculosis in 2004, 45% 
were African-Americans.  Although rates of tuberculosis in US-born blacks, as well as whites, 
have declined substantially over the past decade, since 1993.  US-born blacks have consistently 
had tuberculosis rates eight times higher than US-born whites. 
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In 2000, 53% of reported cases were among US-born persons (3.5 cases per 100,000 population), 
while 47% occurred among foreign-born persons (25.3 cases per 100,000 population).  In 
comparison, in 2004, 46% of the reported cases occurred among US-born persons (2.6 cases 
per 100,000) and 54% occurred among foreign-born persons (22.8 cases per 100,000), the 
third consecutive year that foreign-born persons represented a majority of cases (Figure 25). 
The top five countries of origin of foreign-born persons with tuberculosis were Mexico, the 
Philippines, Vietnam, India, and China. 
In 2004, the age group with the highest case tuberculosis rate consisted of persons 65 years 
of age or older (7.8 cases per 100,000 population), closely followed by those 25–44 years of 
age and 45–64 years of age, each with a case rate of 5.9 per 100,000 population. The largest 
declines (22%) occurred in persons 65 years and older, from a rate of 10 cases per 100,000 
population in 2000 to 7.8 in 2004. Among persons 45–64 years of age, reported cases declined 
20.3%, from 7.4 cases per 100,000 population in 2000 to 5.9 in 2004.
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What is CDC Doing to Help Reduce Health Disparities in
HIV/AIDS, Viral Hepatitis, STDs, and Tuberculosis?
CDC plays a major leadership role in carrying out the goals set forward in Healthy People 
2010, including the goal to eliminate racial and ethnic disparities in health. To help accomplish 
this goal, CDC has launched agency-wide and disease-specific initiatives; developed culturally 
appropriate, community-driven programs; collaborated with community and government 
partners on prevention and intervention research; developed educational outreach activities for 
the community and for CDC employees; and implemented programs to increase diversity in the 
public health workforce. Some of CDC’s activities to address disparities in HIV/AIDS, viral 
hepatitis, STDs, and tuberculosis are described below. For the purposes of this report, initiatives 
include guidelines and recommendations, strategic plans, workgroups, and consultations.  The 
term program generally refers to activities that take place under CDC funding at the local, 
community, and state levels. 
Initiatives
HIV/AIDS
The majority of the Division of HIV/AIDS Prevention’s resources are dedicated to further 
understanding and addressing disparities among population groups that are disproportionately 
affected by HIV/AIDS.  Initiatives include revising HIV testing recommendations, mobilizing 
community leaders, and conducting consultations to address HIV/AIDS in African Americans, 
Hispanics, women, and MSM.  In addition, CDC targets programs to these groups to reduce 
their risk of getting HIV and to help those infected with HIV to live healthy lives and reduce 
the transmission to others. 
In September 2006, CDC released Revised Recommendations for HIV Testing of Adults, 
Adolescents, and Pregnant Women in Health-Care Settings. The document encourages routine 
HIV screening of adults, adolescents, and pregnant women in healthcare settings in the United 
States. CDC also recommends that MSM get tested at least annually.  Increased testing will 
enable those who are infected with HIV to get into treatment that can improve their health 
and extend their lives and reduce further transmission of the virus. HIV testing is especially 
important for MSM of racial or ethnic minorities, as research has shown that black and Hispanic 
MSM who are infected with HIV enter treatment at a later stage than their white counterparts.
In January 2001, CDC released a 5-year HIV Prevention Strategic Plan with an overarching 
goal of  significantly reducing the number of new HIV infections in the United States by 2005 
(70). The plan was updated in 2007. The plan focused primarily on eliminating racial and ethnic 
disparities in new HIV infections. New programs were implemented that helped to improve 
treatment, care, and support for persons living with HIV, funded HIV prevention behavioral 
interventions for uninfected persons at high risk for HIV, and strengthened the capacity and 
infrastructure of community-based organizations (CBO) that provide HIV prevention and care 
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services. However, disparities continue to persist among racial and ethnic minority populations, 
especially African Americans. To further reduce the incidence of HIV, CDC announced the 
Advancing HIV Prevention (AHP) initiative in 2003 (71). AHP, which focuses on people at 
greatest risk for transmitting HIV and their partners, consists of four strategies: (1) making 
HIV testing a routine part of medical care, (2) implementing new models for diagnosing HIV 
infections outside medical settings, (3) preventing new infections by working with HIV-infected 
persons and their partners, and (4) further reducing perinatal transmission. 
In 2005, CDC established a workgroup to address HIV/AIDS in African Americans, charging it 
with carrying out two tasks. The first task was to engage new partners to help mobilize African-
American communities for a heightened, collaborative response to the HIV/AIDS epidemic. 
A consultation, which included representatives of faith- and community-based organizations, 
media, clinical organizations, and African-American sororities and fraternities, was convened 
in 2006. The second task charged the workgroups with developing a CDC action plan outlining 
an urgent response to the epidemic among African Americans. The action plan was linked to 
goals and objectives contained in the HIV Prevention Strategic Plan and to recommendations 
from consultation participants. These goals and objectives included new activities to expand 
partnerships, conduct and integrate research, develop and evaluate programs, and collaborate 
with media and other communications channels to disseminate information. Building on this, in 
2007, CDC launched A Heightened National Response to the HIV/AIDS Crisis Among African 
Americans.   The Heightened National Response focuses on four main areas: (1) expanding 
the reach of prevention services; (2) increasing opportunities for diagnosing and treating HIV; 
(3) developing new, effective interventions; and (4) mobilizing broader community action 
(72). In March 2007, CDC supported a consultation with African-American leaders from 
health departments, community-based organizations, local businesses, the faith community, 
and nontraditional partners, such as media and entertainment groups to publicly commit 
to strengthening the national response to the high rates of HIV/AIDS in African-American 
communities.  During the consultation, African-American leaders made public commitments 
to intensify their HIV prevention efforts. These efforts will be evaluated by CDC. In addition 
to this consultation, CDC has convened other consultations, including an August 2005 
consultation to enhance HIV prevention programs and research activities directed toward 
African-American men who have sex with men.  In addition, in June 2007, CDC sponsored 
the HIV/AIDS and African American Women: A Consultation Supporting CDC’s Heightened 
National Response to the HIV/AIDS Crisis among African Americans.  Also, in October 2007, 
CDC, the National Institutes of Health, and the Health Resources and Services Administration 
co-sponsored the Consultation to Address Intervention Strategies for HIV/AIDS Prevention 
with African Americans.  CDC is also working internally and with external partners to examine 
and further improve HIV prevention efforts for Hispanic as well as MSM populations.
Viral Hepatitis
Historically, hepatitis A incidence in the United States has been substantially higher among 
AI/AN than in other racial and ethnic populations in the United States (73). The high rates 
of hepatitis A among AI/AN populations were largely the result of periodic community-
wide epidemics on reservations and in rural Alaskan communities. In 1996, the Advisory 
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Committee on Immunization Practices first recommended routine hepatitis A vaccination of 
AI/AN children. CDC collaborated with the Indian Health Service (IHS) in implementing pilot 
programs in a few areas and then in expanding coverage. Rates of hepatitis A virus among
AI/ANs have decreased dramatically since the widespread vaccination program was introduced. 
In 2003, rates were the same as or lower than those in other races. Through another collaborative 
agreement between CDC, the IHS, and the Tanana Chiefs Conference, a CDC-supported 
demonstration project called the Viral Hepatitis Integration Project is under way in central 
Alaska. Viral hepatitis, HIV, and STDs share risk factors, and Alaska Natives have a higher 
risk for these diseases compared with other Alaskans. For this project, “integration” refers to 
the delivery of comprehensive hepatitis, HIV, and STD prevention services in locations where 
patients may be at risk, but where such services have not previously been offered together. 
STDs
Prior to the launch in October 1999 of the National Plan to Eliminate Syphilis from the United 
States, syphilis was one of the most glaring examples of racial disparities in the burden of 
disease between African Americans and whites. From 1997 to 2003, however, there was a 
75% reduction in the number of infectious syphilis cases in African-American women. CDC 
collaborated with Federal, state, local, and nongovernmental partners to develop the National 
Plan to Eliminate Syphilis (74). In the plan, CDC identified the following key strategies 
needed for successful elimination of syphilis from the United States:  expanded surveillance 
and outbreak response activities, rapid screening and treatment in and out of medical settings, 
expanded laboratory services, strengthened community involvement and agency partnerships, 
and enhanced health promotion. Since the implementation of the plan 6 years ago, numerous 
gains have been made in reducing the national incidence of syphilis, in raising professional 
and public awareness of the disease, in increasing financial investment into public STD clinic 
services, and in building the capacities of local public health departments and CBOs to provide 
prevention services. The evolving epidemiology of syphilis, including changes in risk groups 
and regions where it is concentrated, presents challenges to elimination of the disease. As in 
the issue of HIV/AIDS, socioeconomic factors continue to drive the concentration of STDs in 
those with high-risk behaviors, poor access to care, or both; the disease is largely concentrated 
in African Americans in the Southeastern states. 
In reframing the future of the Syphilis Elimination Effort, CDC’s vision is to create an evidence-
based and culturally competent prevention and control action plan with three key goals: (1) 
investment in and enhancement of public health services; (2) prioritization of evidence-based, 
culturally competent interventions; and (3) creation of accountable services and interventions. 
In 2006, a revised National Plan to Eliminate Syphilis from the United States was launched 
to provide a strategic framework and action plans to continue progress towards eliminating 
syphilis from the United States.
In June 2007, CDC sponsored the Consultation to Address STD Disparities in African-American 
Communities.  The consultation included experts in a variety of fields with perspectives on public 
health, infectious diseases, and health in African-American communities.   Participants in the 
consultation represented academia, Federal and local government, faith-based organizations, 
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grassroots organizations, and the private sector.  The consultation focused on the causes of 
racial disparities in STD rates as well as on how best to combat them. CDC and partners will 
follow up on implementing recommendations that were derived from the consultation. 
Tuberculosis
Tuberculosis rates among racial and ethnic minorities are substantially higher than rates 
among whites, and the disease persists among foreign-born persons and U.S.-born blacks (75). 
Several factors likely contribute to the burden of tuberculosis in these populations, including 
an unequal distribution of such risk factors as HIV infection. Since 2003, CDC has responded 
to the epidemic among blacks with a Stop TB in the African-American Community initiative. In 
2003, the Advisory Council for the Elimination of Tuberculosis (ACET) and CDC cosponsored 
a consultation with national nongovernmental, African-American organizations and agencies 
whose programs could have an impact on tuberculosis control efforts in the African-American 
population. The discussion groups identified a number of unmet needs and provided important 
comments and specific recommendations for activities to raise awareness and stimulate actions 
to address and reduce tuberculosis in racial and ethnic minorities. In 2006, CDC held a summit 
to engage new partners to create links and build networks that will lead to ongoing activities 
and strategies to decrease tuberculosis in the African-American community. In addition, CDC 
launched a “Stop TB in the African-American Community” listserv and Web page.  
Programs
CDC provides leadership, capacity-building assistance, and funding for programs at the state, 
local, and community levels. CDC funding supports staffing, program infrastructure, program 
implementation, and evaluation of interventions. CDC strives to ensure that programs meet 
local needs and that they are science-based and culturally proficient. Selected prevention 
programs are described below.
HIV/AIDS
The majority of the Division of HIV/AIDS Prevention’s program resources are dedicated 
to addressing disparities among population groups that are disproportionately affected by 
HIV/AIDS, in particular, racial and ethnic minorities. HIV prevention programs consist of 
interventions intended to change risky behavior and improve the health of the people served. 
Interventions include encouraging early HIV diagnosis; providing HIV counseling, testing, and 
referral services; developing educational programs and materials; and training peers to deliver 
educational messages. CDC has partnered with community- and faith-based organizations and 
business and labor groups to help deliver some of these interventions. To reach populations 
with high rates of HIV/AIDS, interventions have been delivered to individuals, groups, and 
communities in places such as storefronts, barber shops, beauty shops, health centers, schools, 
housing communities, faith-based organizations, and gay bars. Street outreach techniques, such 
as using mobile testing vans, offering incentives for participation or referral, and recruiting 
peers, are some of the ways to reach people with limited access to care and those who may be 
homeless.  In addition, community planning helps ensure that priorities for HIV prevention 
are determined locally with input from affected communities and that they meet the needs and 
values of the populations they serve.
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Through the Replicating Effective Programs (REP) project and the Diffusion of Effective 
Behavioral Interventions (DEBI) project, CDC develops and provides culturally competent, 
evidence-based HIV prevention interventions for persons at risk of acquiring or transmitting 
HIV. REP/DEBI projects are the cornerstones of a national prevention program (76, 77). The 
interventions target specific racial and ethnic populations at high risk for HIV infection. Many 
of the DEBI projects are targeted to racial and ethnic minorities, and they were tested with 
representatives from racial and ethnic communities.  CDC funds health departments, community-
based organizations, and other partners across the United States to provide these interventions 
to the populations they serve. Interventions found to be effective for persons of color include 
training black youth as peer educators in their communities; teaching healthcare providers 
how to work with young black and Latino/Hispanic MSM and heterosexuals in prevention 
activities; using culturally appropriate videos to teach small groups of sexually active black 
and Latino/Hispanic men and women about condom use, negotiation skills, and safer sex; 
offering HIV counseling and testing services and outreach activities to black churches; and 
offering outreach, discharge planning, community case management, and education services 
to correctional institutions (76, 77). Some examples of these interventions are highlighted 
below:
•	 Healthy Relationships, a small-group intervention for people living with HIV and 
AIDS
•	 Many Men, Many Voices (3MV), a group-level STD/HIV prevention intervention for 
African-American men who have sex with men (MSM) of color
•	 Popular Opinion Leader (POL), an intervention to identify opinion leaders to encourage 
safer sex as the norm in social networks of MSM 
•	 Safety Counts, an intervention for active injection drug and crack cocaine users, aimed 
at reducing high-risk drug use and sexual behaviors
•	 Sisters Informing Sisters About Topics on AIDS (SISTA), a group intervention for 
African-American women to help them increase condom use
•	 Street Smart, a skills-building program to help runaway and homeless youth practice 
safer sexual behaviors and reduce substance abuse
Other programs that help reduce disparities in HIV/AIDS include the Minority AIDS Initiative 
(MAI), which provides funding for HIV prevention resources for programs targeted to 
communities of color, including activities to build capacity for HIV prevention. Another source 
of funding is Supplemental Funding for Community-based Strategies to Increase HIV Testing 
of Persons at High Risk in Communities of Color. These funds support a social network model 
to increase HIV counseling and testing among high-risk minority communities. CDC also 
works with media and other communications channels to deliver HIV prevention messages. 
Newspapers, local radio stations, magazines, and trade shows that target racial and ethnic 
minorities have partnered with the agency on projects. The Black AIDS Institute, a black HIV/
AIDS policy center, is funded by CDC for two important media-related projects. For example, 
the Drumbeat Project uses media messages to influence the way black America views the 
AIDS epidemic and to fight stigma and homophobia that may impede HIV testing, treatment, 
and mobilization efforts in the African-American community. The second project involves the 
use of communications modalities (e.g., media and town hall meetings). CDC also conducts its 
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own social marketing campaigns to communicate important HIV-related messages to relevant 
communities. For example, “Take Charge, Take the Test” targets African-American women in 
select urban areas to encourage them to get tested for HIV.
Viral Hepatitis
To help address disparities in viral hepatitis among AI/AN, CDC supports two staff members 
who coordinate joint CDC/Indian Health Service activities around viral hepatitis epidemiology, 
research, prevention, and policy. CDC also supports long-term follow-up of groups of American 
Indians and Alaska Natives vaccinated for hepatitis A and hepatitis B to ensure that protection 
from these viruses continues for many years after vaccination. In addition, efforts to determine 
the causes of chronic liver disease in these populations and the factors that contribute to more 
severe chronic liver disease are supported. 
Sexually Transmitted Diseases
The Syphilis Elimination Effort, described elsewhere in this report, is a national initiative that 
includes goals to reduce disparities in syphilis. The Infertility Prevention Project is a national 
program that funds chlamydia and gonorrhea screening and treatment services for low-income, 
sexually active women attending clinics for family planning, sexually transmitted diseases, 
and other women’s healthcare needs. To address disparities in AI/AN, CDC funds projects to 
strengthen the local capacity of American Indian communities on Native American reservations 
to decrease STDs. One project is creating awareness among tribal or reservation councils about 
STDs in their communities and about how to prevent STDs. Another project is working with 
CDC’s Prevention Training Centers to develop collaborations with state health departments, 
regional infertility prevention programs, the IHS, tribal epidemiological centers, and other 
relevant partners for sharing resources and information that could strengthen an STD program. 
CDC also assists state STD programs to design, implement, and evaluate Comprehensive STD 
Prevention Systems, including strategies specific to the prevention of STD-related infertility 
and to the elimination of syphilis. 
Tuberculosis
Current tuberculosis control, treatment, and prevention programs are being strengthened to 
ensure their capacity for diagnosing and properly treating people with active tuberculosis 
and thus prevent the spread to others. One program that was developed to accomplish this 
goal is the U.S.-Mexico Binational Referral and Case Management  Project (Binational Card 
Project). The Binational Card Project is a collaborative effort between CDC and the National 
Tuberculosis Program in Mexico to ensure continuity of care and completion of therapy for 
tuberculosis patients migrating across the border, to reduce tuberculosis incidence and prevent 
drug resistance, to coordinate referral of patients between health systems, and to provide a 
model for addressing other diseases. 
Another CDC goal is to mobilize support for tuberculosis elimination. To accomplish this goal, 
CDC has consulted with leaders, organizations, healthcare providers, and other stakeholders 




NCHHSTP’s research agenda includes studies to monitor patterns of disease in different 
populations and to identify factors associated with increased risk of disease. The results of 
these studies are used to develop and evaluate programs to address health disparities in HIV/ 
AIDS, viral hepatitis, STDs, and tuberculosis.  
HIV/AIDS
HIV/AIDS research includes epidemiologic studies and analyses of surveillance data in an 
effort to better characterize behavioral trends and determinants of HIV risk and infection in 
understudied groups, including African Americans, Hispanics/Latinos, and others who have 
been disproportionately affected by HIV/AIDS.
In addition, multiple intervention studies that test new and innovative strategies for reducing 
HIV risk in disproportionately affected populations, including biomedical approaches, are 
conducted.  These intervention studies focus on African-American and Hispanic/Latino 
women, MSM, heterosexual men, and persons living with HIV, as well as substance-using 
MSM, young incarcerated men, homeless and unstably housed persons living with HIV, 
transgender persons, and other populations.  A number of these studies seek to address social 
and structural determinants of HIV risk, such as poverty, homelessness, and the effects of racism 
and discrimination.  The Division of HIV/AIDS Prevention is also conducting research to 
identify optimally effective strategies to get at-risk persons to know their HIV status, to reduce 
undiagnosed HIV infection among African-American men and women, to increase access to 
care among persons who are diagnosed with HIV, and to increase access and utilization of 
HIV prevention services among Latinas living along the U.S.-Mexico border.  In addition, the 
Division of HIV/AIDS Prevention is working to increase the number of investigators working 
to reduce HIV-related health disparities.  In 2002, CDC created the Minority AIDS Research 
Initiative (MARI). The MARI program is a capacity-building initiative to fund investigators 
to conduct studies that address gaps in HIV/AIDS research in African-American and Latino/
Hispanic populations.
Viral Hepatitis
To address disparities in viral hepatitis among minorities, the Division of Viral Hepatitis 
supports research on African-American and Hispanic/Latino injection drug users as well as 
studies of acute hepatitis B and hepatitis A in minority communities.  The Division of Viral 
Hepatitis supports field staff responsible for coordinating joint CDC/Indian Health Service 
activities around viral hepatitis epidemiology, research, prevention, and policy.  The Division 
of Viral Hepatitis also supports long-term follow-up for groups of American Indians and Alaska 
Natives vaccinated for hepatitis A and for hepatitis B to ensure that protection from these 
viruses continues for many years after vaccination.  A series of studies in Pacific Island nations 
that were or are US trust territories—American Samoa, Chuuk (formerly Truk), Pohnpei, and 
the Marshall Islands—are evaluating the preservation of immune function in adolescents and 
young adults vaccinated in infancy for hepatitis B.  In addition, efforts to determine the causes 
of chronic liver disease in these populations and the factors that contribute to more severe 




Research on STDs includes an examination of how diagnosis of a high-risk strain of the human 
papillomavirus affects African-American, Latino/Hispanic, and white women and their sexual 
partners; an evaluation of the degree to which STDs and viral hepatitis control and prevention 
services are integrated into public and private HIV clinical care settings that provide services to 
African-American, Asian, and Latino/Hispanic MSM; and an examination of racial and ethnic 
disparities in prenatal syphilis screening and treatment among Medicaid patients in Florida and 
Georgia. Studies on viral hepatitis prevention include follow-up of a group of Alaska Native 
infants, children, and adults initially vaccinated with hepatitis A or hepatitis B vaccines 5 - 22 
years ago to evaluate the protection afforded by the vaccination. In addition, groups of adults 
with chronic hepatitis B or chronic hepatitis C will be evaluated to determine outcomes of 
infection and the influence of additional risk factors.
Tuberculosis
Tuberculosis research includes a project titled “Addressing Tuberculosis Among African 
Americans in the Southeast.” The objectives of the project are to determine barriers to 
health-seeking behavior and treatment adherence for African Americans with or at risk for 
tuberculosis; to determine barriers to tuberculosis guideline adherence among providers who 
serve this population; to develop and test interventions to overcome identified barriers; and to 
improve partnerships and collaborations among tuberculosis programs and the providers and 
organizations serving this population. To address disparities in tuberculosis among foreign-born 
populations, CDC has sponsored several studies.  The Division of Tuberculosis Elimination 
(DTBE) has funded an epidemiologic research study of the determinants of early diagnosis, 
prevention, and treatment of tuberculosis among foreign-born individuals. In addition to the 
epidemiologic study, DTBE supports a research project to assess the tuberculosis-related 
attitudes and beliefs of foreign-born persons in the United States. Findings from in-depth 
interviews conducted among persons (with and without tuberculosis disease) from China, 
Laos, Mexico, Somalia, and Vietnam will be used to create ethnographic guides for health care 
providers.   DTBE has also funded a research project to understand the barriers and facilitators 
that influence primary care management of latent and active tuberculosis among immigrant 
populations. The objectives of the research are to describe the factors influencing the diagnosis 
and the efficient management of latent and active tuberculosis among primary care providers 
treating immigrants from Mexico, the Philippines, and Vietnam. Finally, DTBE has also funded 
a project to determine the epidemiologic and geographic profile of tuberculosis cases among 
Asians and Pacific Islanders in the United States. This project will provide information to help 
in developing specific prevention strategies and in allocating resources for this population. 
Educational Outreach
NCHHSTP engages in or supports education and outreach to help eliminate health disparities in 
HIV/AIDS, viral hepatitis, STDs, and tuberculosis. Training is provided to medical and public 
health practitioners and others through STD/HIV and tuberculosis training centers, initiatives 
with Historically Black Colleges and Universities (HBCU), and activities with partners, such 
as CDC’s participation in the Migrant Stream Farmworkers Forums. In addition, educational 
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outreach includes the creation and distribution of guidelines, recommendations, and supporting 
educational materials addressing specific populations (e.g., the foreign-born, racial or ethnic 
minorities, and MSM) or targeting providers within specific settings (e.g., correctional facilities 
and substance abuse treatment centers).  
The STD/HIV training centers serve as a national network to design, deliver, and evaluate 
training that targets healthcare providers and prevention specialists. Similarly, the tuberculosis 
Regional Training and Medical Consultations Centers (RTMCCs) provide training and 
technical assistance to increase human resource development in tuberculosis programs; to 
develop tuberculosis educational materials; and to provide medical consultation to tuberculosis 
programs and medical providers. 
An HBCU initiative includes providing technical assistance to schools participating in the 
Consortium of African-American Public Health Programs. In addition, the Migrant Stream 
Farmworkers Forums provide a variety of workshops and sessions on current issues, policy, 
and programs related to HIV, viral hepatitis, STDs, and tuberculosis infections and other 
health issues in migrant populations. Furthermore, NCHHSTP has supported or coordinated 
several initiatives and events, including a media roundtable for black journalists, activities 
to increase awareness about HIV/AIDS prevention among black students, and national HIV/
AIDS awareness days that help to raise awareness and spread information about HIV/AIDS. 
These annual national awareness days include the National Black HIV/AIDS Awareness and 
Information Day (February 7), National Women and Girls HIV/AIDS Awareness Day (March 
10), National Native HIV/AIDS Awareness Day (March 21), National Asian and Pacific 
Islanders HIV/AIDS Awareness Day (May 19), and National Latino AIDS Awareness Day 
(October 15). Finally, syphilis elimination outreach activities include prevention education in 
minority communities.
To help bring visibility to health disparities in HIV/AIDS, STDs, viral hepatitis, and tuberculosis 
within the CDC community, in 2005, NCHHSTP inaugurated the Third Thursdays: Lunch 
and Learn Health Disparities Lecture Series. The “Third Thursdays” lunch-and-learn lecture 
series was developed to highlight research and programs aimed at reducing disparities in HIV, 
viral hepatitis, STDs, and tuberculosis.
Workforce Diversity
In order to address the healthcare needs of this nation’s diverse population in an effective and 
culturally sensitive manner, CDC has implemented training programs and related activities 
to help ensure that the public health workforce is also diverse. The training programs focus 
primarily on increasing the interest, representation, and competence of racial and ethnic 
minority students, researchers, and health professionals in public health. This includes support 
for internships and fellowships within NCHHSTP. For example, the Research Fellowship 
on HIV Prevention in Communities of Color supports the training of scientists researching 
sociocultural, structural, psychological, and behavioral factors in minority health and HIV. 
There are summer internships for AI/AN, African-American, and Latino-Hispanic colleges 
and graduate students. An annual biomedical symposium fosters learning among minority 
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high school and college students about and fosters a commitment to professions in medicine, 
science, and research. In addition, a tribal college that offers an Associate of Science degree 
program in public health receives support for curricula development, and a Consortium of 
African-American Public Health Programs at HBCU schools that offer a master’s degree in 
public health (MPH) and a doctorate in public health (DrPH) receives support to develop 
schools of public health. 
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Priorities and Recommendations for Future Action to
Address Health Disparities
As discussed in this report, the factors that influence health disparities are multifaceted. They 
include poverty, unequal access to health care, educational level, racism, geographic location, 
and social networks, as well as other factors. While it is clear there are health disparities with 
respect to HIV/AIDS, viral hepatitis, STDs, and tuberculosis, the solutions for addressing 
those disparities are less clear.  In considering solutions, it is important to be aware of the 
varied influences on health disparities.  These influences have been described in this report 
and by others elsewhere (27, 78). The priorities for future action presented in this section 
attempt to acknowledge the role of individuals, communities, policymakers, the health care 
system, as well as the underlying social and economic conditions that contribute to health 
disparities. Despite the complex nature of health disparities, this section provides priorities 
to which the CDC is committed in order to influence policy, planning, and action to reduce 
health disparities.  These priorities include enhancing and improving partnerships, increasing 
screening and testing for diseases in populations with known health disparities, adopting an 
integrated service model to improve health care delivery, improving monitoring through the 
enhancement of current data systems and the development of new systems, and adopting new 
diagnostic, treatment, and prevention technologies (79).
Partnerships
Reducing and eliminating health disparities cannot be achieved by a single agency or group; 
rather, the task will require partnerships from individuals, communities, agencies, community-
based organizations, policymakers, the public and private health care sectors, and others. 
Strengthened collaborations with local, state, national, and international partners from all sectors 
of society will help reach individuals at the highest risk for HIV/AIDS, viral hepatitis, STDs, 
and tuberculosis.  These collaborations and partnerships will assist in identifying innovative 
strategies to improve testing and treatment among high-risk populations. Partners can help 
provide education, change perceptions, motivate people to seek diagnosis and treatment, and 
encourage health behaviors that prevent the spread of disease. Moreover, partnerships are not 
only important for addressing the diseases described in this report, but also for understanding 
and addressing other social and economic conditions that often contribute to health disparities. 
Partners are essential to help change the risk environment from which many health disparities 
are derived by addressing issues such as housing, employment, homelessness, mental health, 
substance abuse, racism, homophobia, and stigma (79, 80).  New partnerships with non-
traditional partners should be formed with representatives from all sectors of society, including 
health, social service (e.g., substance abuse treatment and housing providers), faith, civic, 
entertainment, and business sectors. 
Although new partnerships are essential, it is also important to strengthen existing relationships 
with public health partners.  In addition, improved collaboration among governmental agencies 
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is important to provide a unified public health infrastructure for research, prevention, treatment, 
and care for HIV/AIDS, viral hepatitis, STDs, and tuberculosis (79). Efforts must be made to 
sustain and build upon these partnerships and to evaluate the usefulness of enhanced and new 
partnerships for addressing health disparities.
Screening and Testing for Infectious Diseases
To reduce the number of persons with undiagnosed HIV/AIDS, viral hepatitis, STDs, and 
tuberculosis, new efforts are needed to increase access to screening and testing services. Health 
disparities will be reduced by targeting screening and testing services for individuals who 
are at highest risk for these diseases and who have the greatest health disparities.  Enhanced 
screening and testing can increase the number of persons who are aware of their infection, can 
decrease disease transmission to others, and can link infected individuals to care, treatment, and 
prevention services. Efforts should be made to spread the message for testing among high-risk 
populations where they live, work, play, and worship. In addition, efforts to increase screening 
and testing should target providers to make testing for HIV/AIDS, viral hepatitis, STDs, and 
tuberculosis standard for populations at greatest risk for these diseases. Finally, strategies should 
be considered to enhance screening and testing services offered by community organizations 
and other partners that serve populations at highest risk for these diseases. 
For HIV and other STDs, testing is important, for it can provide the impetus for infected 
individuals to begin treatment.  Persons who know they are infected with HIV or another 
sexually transmitted disease are also more likely to change their behavior to prevent themselves 
from transmitting the disease to others (81).  Testing also provides the opportunity to identify 
other sexual partners who are at risk of having the disease.
For tuberculosis, it is important to identify individuals with tuberculosis disease to prevent 
these individuals from spreading the disease to others.  The identification of individuals with 
tuberculosis disease often leads to the initiation of a contact investigation to identify others who 
may have been exposed to someone with infectious tuberculosis disease. It is also important 
to identify individuals with latent tuberculosis infection who may develop active tuberculosis 
disease at some time in the future. Targeted tuberculin testing for latent tuberculosis infection is 
a strategic component of tuberculosis control that identifies persons at high risk for developing 
tuberculosis who would benefit from treatment if the disease is detected. 
While vaccines for hepatitis A and hepatitis B exist, persons already infected with hepatitis 
can benefit from hepatitis screening, care, and treatment to protect their health and prevent 
transmission to others. For example, treatment for chronic hepatitis B is increasingly effective; 
however, many individuals with hepatitis B may be unaware they have the disease, specifically 
persons from countries where hepatitis infection is endemic (82).   
 
Testing and screening activities should be targeted to the populations that experience the 
greatest health disparities for HIV/AIDS, viral hepatitis, STDs, and tuberculosis.  Increased 
testing and screening activities for HIV/AIDS, viral hepatitis, STDs, and tuberculosis will 
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help identify individuals most at risk for these diseases and contribute to reducing the health 
disparities associated with them.
Collaborative and Integrated Programs
One approach that may address health disparities for individuals with HIV/AIDS, viral hepatitis, 
STDs, and tuberculosis is to improve screening, treatment, care, and prevention services through 
program collaboration and service integration.  Integrated services seek to organize and blend 
interrelated health issues and services in order to maximize public health impact through new 
and established linkages to facilitate the delivery of services.  The rationale cited for integrated 
service delivery for HIV/AIDS, viral hepatitis, STDs, and tuberculosis includes the following: 
(1) the diseases have similar or overlapping at-risk populations; (2) there is a similarity of risk 
behaviors among at-risk populations; (3) the diseases feature significant co-morbidity among 
population groups; (4) there exist advances in HIV and STD testing technology that make 
testing easier to conduct; and (5) disease outcomes are influenced by concurrent disease.
Program collaboration is necessary to facilitate service integration. Efforts should be focused 
in the clinical setting, where the interface between the health system and the client takes place. 
Integration may result in more holistic and comprehensive services for patients. Integrated 
approaches are not limited to addressing HIV/AIDS, viral hepatitis, STDs, and tuberculosis. 
They may also address other relevant diseases, as well as address other issues that contribute to 
health disparities, such as mental health and substance abuse services.  Integration efforts can 
extend beyond the clinical setting. They can also take place with governmental and community 
organizations, as well as with social service providers. In addition, within CDC, integration 
efforts can build collaborations across the HIV/AIDS, STDs, viral hepatitis, and tuberculosis 
prevention programs. Local, state, and Federal efforts toward program collaboration and 
integration related to the prevention and treatment of HIV/AIDS, STDs, viral hepatitis, and 
tuberculosis may help reduce health disparities by enhancing the public health impact of 
screening, treatment, and prevention programs.
Improved Monitoring for Infections and Effectiveness of Prevention Programs 
Reliable and accurate surveillance data are the cornerstone to public health activities. 
Population-based data are essential to tracking and understanding the distribution of HIV/
AIDS, STDs, viral hepatitis, and tuberculosis disease in the United States.  Surveillance data 
indicate disease trends and are the foundation for identifying health disparities among population 
groups disproportionately affected by HIV/AIDS, STDs, viral hepatitis, and tuberculosis. In 
addition, data systems that measure the implementation of prevention programs will assist in 
the evaluation of the effectiveness of reaching individuals most at risk for HIV/AIDS, STDs, 
viral hepatitis, and tuberculosis, and they may help identify effective prevention programs 
worth expanding, as well as programs in need of improvement.
Understanding the burden of diseases among different populations allows for setting priorities 
and allocating resources for testing, treatment, and prevention services. Improved monitoring of 
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diseases should take place through the enhancement of current data systems and the development 
of new systems.  If they do not already exist, monitoring systems need to include measures to 
differentiate between race/ethnicity, socioeconomic factors, health care access, risk factors, risk 
behaviors, co-morbid health conditions, as well as other factors that may contribute to health 
disparities.  New data systems should be developed to refine estimates of disease incidence, as 
well as to monitor and evaluate prevention programs at the local level.  Detailed surveillance 
analyses for subpopulations with documented health disparities will help to further understand 
the factors that need to be addressed to reduce and eliminate health disparities.  Accurate, 
comprehensive data allow programs and policymakers to better understand what is causing 
disparities and to know where resources should be directed.  Improved monitoring can assist in 
the identification of target areas where interventions should be implemented to address health 
disparities. 
New Technologies
An important priority in addressing health disparities is improving the access to and the 
acceptability of new technologies in assessing the incidence of HIV/AIDS, STDs, viral 
hepatitis, and tuberculosis, for access to medical, health, and prevention technologies is not 
consistently distributed among population groups in different types of health care settings 
(67).  Prevention technologies include vaccines, diagnostic tests (e.g., rapid HIV tests and the 
blood test for tuberculosis infection), and prevention tools, such as microbicides, as well as 
effective behavior-change interventions.  As new technologies become available, resources 
will be needed to provide access to these tools consistently across all health care settings. 
Settings that disproportionately serve uninsured or poor populations, such as public hospitals, 
public health clinics, and community health centers, are more likely to face financial and 
human resource constraints that discourage or prevent the use of new technologies (67).  In 
addition, even when new technologies become available, special efforts are needed to ensure 
that new tools are acceptable to the populations experiencing the greatest health disparities. 
Improving acceptability will enhance utilization of important new technologies and tools. 
Efforts to improve acceptability should involve the inclusion of representatives from the 
disproportionately affected populations in the development and testing of new technologies, 
wherever possible.  
In addition, the latest testing and treatment standards and recommendations may not be 
consistently implemented across all settings.  The consistent implementation of the most up-
to-date standards for testing and treatment are important to reducing health disparities. 
Many prevention technologies are still under development, including vaccines, diagnostic 
tests, microbicides, and behavior-change interventions. Resources for the development and 
testing of these innovative efforts must be sustained, and technology gaps must be addressed 




Addressing health disparities in HIV/AIDS, viral hepatitis, STDs, and tuberculosis is a complex 
task. It will require the implementation of priorities for future action. These priorities include 
(1) expanding partnerships to include non-traditional partners; (2) increasing screening and 
testing for infectious diseases in populations at greatest risk for acquiring and transmitting 
diseases; (3) adopting integrated program services focused on delivering more comprehensive 
and holistic services to clients; (4) monitoring infectious diseases through the revision of current 
data systems and the development of new systems to better define populations experiencing 
health disparities and to assess the effectiveness of prevention programs to address disparities; 
and (5) improving access to new technologies in all settings and ensuring that their use is 
acceptable to groups experiencing health disparities.
It is clear that such social determinants of health as racism and socioeconomic factors need 
to be addressed in order to eliminate health disparities in HIV/AIDS, viral hepatitis, STDs, 
and tuberculosis. However, no single public health program can eliminate racial and ethnic, 
socioeconomic, and gender inequities or homophobia. Therefore, it is important to be realistic 
about what can be achieved when goals and objectives for programs are developed. CDC will 
continue to work with partners in the community, with healthcare providers, with legislators, 
and with other stakeholders to identify collaborative activities that may influence some of the 
social determinants of health that contribute to health disparities in HIV/AIDS, viral hepatitis, 
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